Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要